title: Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD.
authors.forename: V
authors.initials: V
authors.lastname: Brusasco
authors.forename: R
authors.initials: R
authors.lastname: Hodder
authors.forename: M
authors.initials: M
authors.lastname: Miravitlles
authors.forename: L
authors.initials: L
authors.lastname: Korducki
authors.forename: L
authors.initials: L
authors.lastname: Towse
authors.forename: S
authors.initials: S
authors.lastname: Kesten
mesh_terms: D000420:Albuterol / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D006801:Humans; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage*; D000069447:Tiotropium Bromide; D016896:Treatment Outcome
chemical_list: D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives; D000420:Albuterol; D000069447:Tiotropium Bromide